Virtus Investment Advisers, Inc. Silence Therapeutics PLC Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 16,837 shares of SLN stock, worth $120,721. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,837
Previous 24,872
32.31%
Holding current value
$120,721
Previous $70,000
38.57%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
57Shares Held
20.6MCall Options Held
22.8KPut Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$21.8 Million3.59% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$20.9 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.16MShares$15.5 Million1.53% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$13.3 Million0.9% of portfolio
-
Morgan Stanley New York, NY1.21MShares$8.69 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $257M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...